Lessons From Local Evidence Generation to Strengthen Fit-for-Purpose RWE

• Drives the strategic design and oversight of non-interventional RWE initiatives using primary data collection, secondary healthcare data sources and hybrid approaches to generate fit-for-purpose evidence aligned with medical, access and policy needs across therapeutic areas
• Translates local RWE into actionable insights that address medical and access evidence gaps, support reimbursement discussions and inform managed entry agreements

Speakers:

Eleonore Maury

Medical Evidence Manager

Novartis AG